Literature DB >> 9797191

Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats.

A M Sharifi1, J S Li, D Endemann, E L Schiffrin.   

Abstract

OBJECTIVES: To determine whether an angiotensin converting enzyme inhibitor, enalapril, and a dihydropyridine calcium channel antagonist, amlodipine, regress the altered structure, media composition, and vascular relaxation of small arteries of spontaneously hypertensive rats.
METHODS: Spontaneously hypertensive rats aged 10 weeks were treated for 12 weeks with 10 mg/kg per day enalapril or 10-20 mg/kg per day amlodipine and compared with age-matched untreated spontaneously hypertensive rats. Small coronary, renal, mesenteric, and femoral arteries (lumen diameter 200-250 microm) were studied isometrically on a wire myograph, and mesenteric arteries isobarically as pressurized vessels. The composition of the vascular media of the latter was studied by electron microscopy.
RESULTS: Blood pressure, and cardiac and aortic hypertrophy were reduced in treated spontaneously hypertensive rats. Treatment significantly decreased media thickness and media: lumen ratio of coronary, renal, mesenteric, and femoral small arteries studied isometrically and of pressurized mesenteric small arteries. Media cross-sectional area was smaller for coronary arteries studied isometrically and mesenteric arteries studied isobarically. Electron microscopic analysis revealed an increase in collagen: elastin ratio in the media of spontaneously hypertensive rat vessels, and a decrease under treatment to levels found in Wistar-Kyoto rats, with no significant changes detected in smooth muscle cells. The amplitude of contractions induced by acetylcholine on wire-myograph-mounted mesenteric arteries from spontaneously hypertensive rats were decreased by treatment, and relaxation of pressurized arteries induced by acetylcholine was normalized.
CONCLUSION: Treatment of spontaneously hypertensive rats with enalapril or with amlodipine resulted in regression of cardiovascular hypertrophy and amelioration of endothelial dysfunction. Morphometric results obtained using an isometric myograph and a pressurized preparation to study rat small arteries were closely correlated. Regression of structural remodeling in small arteries was outward hypotrophic, with a reduction in the collagen: elastin ratio, and without net change in the absolute and relative volumes of smooth muscle and number of smooth muscle layers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797191     DOI: 10.1097/00004872-199816040-00007

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

Review 1.  Inhibition of the renin angiotensin system: implications for the endothelium.

Authors:  Carmine Savoia; Ernesto L Schiffrin
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 2.  Effects of antihypertensive therapy on hypertensive vascular disease.

Authors:  J B Park; E L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

3.  Transient mesenteric ischemia leads to remodeling of rat mesenteric resistance arteries.

Authors:  Laura Caracuel; Francesc Jiménez-Altayó; Mónica Romo; Ana Márquez-Martín; Ana P Dantas; Elisabet Vila
Journal:  Front Physiol       Date:  2012-01-05       Impact factor: 4.566

4.  Short-term esmolol improves coronary artery remodeling in spontaneously hypertensive rats through increased nitric oxide bioavailability and superoxide dismutase activity.

Authors:  Ana Arnalich-Montiel; María Carmen González; Emilio Delgado-Baeza; María Jesús Delgado-Martos; Luis Condezo-Hoyos; Antonia Martos-Rodríguez; Pilar Rodríguez-Rodríguez; Begoña Quintana-Villamandos
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

5.  Chronic ETA antagonist reverses hypertension and impairment of structure and function of peripheral small arteries in aortic stiffening.

Authors:  Xiaomei Guo; Huan Chen; Ling Han; Stephan Haulon; Ghassan S Kassab
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.